All tenders
BidClosedVerified details
GEM/2026/B/8120020
Lignocaine HCI 2% (Without Adrenaline) 30 ML Inj (Suitable for ophthalmic use also),Inj Diclofenac
Login to Download₹5,000FREE
Published
05 Oct 2026, 08:31 pm
Closes
15 Oct 2026, 09:00 pm
Pre-bid meet
—
Bid opening
16 Oct 2026, 09:00 pm
Financial details
Estimated value—
EMD amount—
ePBG %—
Advisory bank—
Evaluation methodTotal value wise evaluation
Bid validity180 days
Buyer details
MinistryMinistry of Defence
DepartmentDepartment of Military Affairs
OrganisationIndian Army
Office***********
BoQ items (0)
Item details are not yet extracted for this tender.
Consignees (21)
| # | Consignee | Address | Qty | Delivery (days) |
|---|---|---|---|---|
| 1 | *********** | ***********Budgam | 55 | 15 |
| 1 | *********** | ***********Budgam | 350 | 15 |
| 1 | *********** | ***********Budgam | 30 | 15 |
| 1 | *********** | ***********Budgam | 1000 | 15 |
| 1 | *********** | ***********Budgam | 800 | 15 |
| 1 | *********** | ***********Budgam | 80 | 15 |
| 1 | *********** | ***********Budgam | 300 | 15 |
| 1 | *********** | ***********Budgam | 2000 | 15 |
| 1 | *********** | ***********Budgam | 1500 | 15 |
| 1 | *********** | ***********Budgam | 450 | 15 |
| 1 | *********** | ***********Budgam | 1800 | 15 |
| 1 | *********** | ***********Budgam | 100 | 15 |
| 1 | *********** | ***********Budgam | 300 | 15 |
| 1 | *********** | ***********Budgam | 100 | 15 |
| 1 | *********** | ***********Budgam | 3000 | 15 |
| 1 | *********** | ***********Budgam | 2200 | 15 |
| 1 | *********** | ***********Budgam | 180 | 15 |
| 1 | *********** | ***********Budgam | 100 | 15 |
| 1 | *********** | ***********Budgam | 120 | 15 |
| 1 | *********** | ***********Budgam | 60 | 15 |
| 1 | *********** | ***********Budgam | 1500 | 15 |
Exemptions & flags
MSE exemption—
Startup exemption—
OEM required—
Quick facts
Bid ID9988796
Quantity16025
Status1
Details fetched07 Oct 2026, 10:02 am
Contact us about this tender
Need help bidding on this tender? Send us your details and our team will reach out.
